ArticleBreast cancer research : BCR2025

The nonsteroidal anti-inflammatory drug sulindac reverses obesity-driven immunosuppression and triple-negative breast cancer progression.

Michael F Coleman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.